
Sam Edward Mansour MD MSc, FRCS(C), FACS
Retinal Disease
Medical Director, Virginia Retina Center, Clinical Professor, Dept of Ophthalmology, GWU
Join to View Full Profile
45 North Hill Dr202Warrenton, VA 20186
Phone+1 540-349-1882
Fax+1 703-738-7157
Dr. Mansour is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Michael G. DeGroote School of MedicineClass of 1986
- McMaster UniversityM.Sc., Neuroscience, 1981 - 1983
- Queen's UniversityB.Sc., Life Sciences, Honours, 1978 - 1981
- CEGEP De L'OutaouaisD.C.S., Health Sciences, 1977 - 1978
Certifications & Licensure
- CA State Medical License 1991 - Present
- DC State Medical License 2003 - 2027
- VA State Medical License 2002 - 2026
- MD State Medical License 2002 - 2015
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Achievement Award 3. American Academy of Ophthalmology, 2000
- HIV Research and Care Award AIDS Community Research Consortium, 1999
- Physician Recognition Award American Medical Association, 1995, 1998
- Join now to see all
Clinical Trials
- Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
- Phase II Combination Steroid and Anti-VEGF for Persistent DME Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 27 citationsThree-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study.Michael A Singer, Veeral Sheth, Sam E Mansour, Brandon Coughlin, Victor H Gonzalez
Ophthalmology. 2022-06-01 - 22 citationsTwo-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN s...Sam E. Mansour, Daniel F. Kiernan, Daniel B. Roth, David A Eichenbaum, Nancy M. Holekamp
The British Journal of Ophthalmology. 2021-03-01 - 120 citationsThe Evolving Treatment of Diabetic RetinopathySam E. Mansour, David J. Browning, Keye Wong, Harry W. Flynn, Abdhish R. Bhavsar
Clinical Ophthalmology. 2020-03-04
Journal Articles
- Retinopathy of prematurity: Where are we today?Pieroga, A.A., Mansour, S.E. and Volpe, M.V., Journal of Neonatal-Perinatal Medicine, 1/1/2012
- MicroPulse™ Laser Therapy of Diabetic Macular Edema Success in Anti-VEGF Non-responderMansour, SE., Retinal Physician, 1/1/2012
- Towards earlier detection of CNV secondary to AMD: multicenter evaluation of a preferential hyperacuity perimeter designed as a home devicePreferential Hyperacuity Perimeter (PHP) Research group, Retina, 1/1/2010
- Join now to see all
Press Mentions
- Alimera Sciences Announces Nine Iluvien® Data Sets to Be Presented at 2017 American Academy of OphthalmologyOctober 28th, 2017
- Press Releases | Loudoun Medical GroupJanuary 16th, 2017
- Severity of AMD in 1 Eye Predicted Likelihood of AMD in Other Eye, Study FoundJune 13th, 2018
- Join now to see all
Professional Memberships
- Fellow
- Member
External Links
- Virginia Retina Centerhttp://wwwvirginiaretina.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: